Average Co-Inventor Count = 10.75
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amylin Pharmaceuticals, Inc. (13 from 164 patents)
2. Astrazeneca Pharmaceuticals LP (8 from 38 patents)
3. Other (1 from 832,912 patents)
14 patents:
1. 9453063 - Hybrid polypeptides with selectable properties
2. 9133260 - GIP analog and hybrid polypeptides with selectable properties
3. 8906849 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
4. 8895498 - GIP and exendin hybrid polypeptides
5. 8697647 - Hybrid polypeptides with selectable properties
6. 8603969 - Pancreatic polypeptide family motifs and polypeptides comprising the same
7. 8598120 - Methods for treatment using amylin family peptides
8. 8497240 - DPP-IV resistant GIP hybrid polypeptides with selectable properties
9. 8426361 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
10. 8404637 - GIP analog and hybrid polypeptides with selectable properties
11. 8263545 - GIP analog and hybrid polypeptides with selectable properties
12. 8114958 - Amylin family peptides
13. 8076288 - Hybrid polypeptides having glucose lowering activity
14. 7723471 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same